Issue 219

Welcome back to E&O: Prescription Digital Therapeutics, a paying subscribers-only weekly newsletter focused on the world of digital pharma products and FDA-regulated digital health.

 E&O: Rx Digital Therapeutics

Here's a quick rundown of things happening in FDA-regulated and pharma-focused digital health:

• News you know: The FDA granted a De Novo clearance to DermaSensor, which aims to "help Primary Care Physicians detect skin